PHARMIVA
Anna Holmberg
Head of Development
Anna is former CEO of Zelmic and Pharmiva. Since the start of Pharmiva in 2015, Anna has been managing and developing the company, from the early stages in product development to its present state of market readiness.
She has over 25 years of experience from managing research and development projects at MIP Technologies, Malmö University, Astra Zeneca, Pharmiva and Zelmic.
In addition to leading operational roles, Anna has also gained experience from board assignments in life science companies and the Danish-Swedish life science cluster organisation Medicon Valley Alliance.
Anna Holmberg holds a M.Sc. in Organic Chemistry and PhD in Physical Chemistry from Lund University
Lars Hedbys
Chief Executive Officer
Lars Hedbys has close to 30 years’ experience from management positions in the life sciences industry. He has a long career with Astra Zeneca including a number of vice president roles in R&D and general management.
Lars has a track record of leading listed companies, large operational organizations, organizations in change and growing life science companies to an IPO.
Currently, Lars is co-founder and Chairman of IAmPatient AB and board member of RhoVac AB (listed on Spotlight Stock Market, Stockholm). He is also co-founder of Idogen AB, Regenesance BV and Casigen Pharma Ltd.
Eva Ståhl Wernersson
Quality and Regulatory Manager
Eva Ståhl Wernersson has been engaged in Pharmiva since 2017, responsible for the technical documentation and the set up of the Quality Management System.
Eva is a founder of Astrad AB and ever since she took her Ph D degree been working in industry in various operative roles. She has over 10 years’ experience as Director Environmental Laboratory at GS Development and an additional 15 years’ as Quality Director at Bioimplant Scandinavia. She has also been engaged in Camurus with quality and regulatory.
She holds a M.Sc. in Chemical Engineering and a PhD in Food Engineering from Lund University.
Per-Ola Forsberg
Chief Financial Officer
Per-Ola is a former business graduate from Lund University with over 25 years of experience in the pharmaceutical and biotechnology industry. During his career, Per-Ola has contributed to three IPOs.
His resume includes positions as CFO at Idogen, LIDDS, Lund University Bioscience and Probi. At Probi, he also served as Vice President, responsible for the company’s business operations.
Prior to that, Per-Ola has held positions as controller at Rexam Beverage Can Fosie and Head of Administration at PolyPeptide Laboratories (a subsidiary of Ferring).
Marie Bolin
International Brand Manager
Marie brings 15 years of experience from commercial roles within the life science industry and pharmacy chains.
Marie has launched numerous products in her previous assignments, Portfolio Manager Sweden at Teva and Nordic Product Manager at Bioglan.
From prior positions at Vårdapoteken and Onemed, Marie also has experience from category management of personal care and OTC products.
Marie holds a M.Sc. in Pharmacy from Uppsala University.